E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 947.5 ILS -1.1% Market Closed
Market Cap: 279.6m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note
EPIT
/
Cash Flow Statement
/
Free Cash Flow

Epitomee Medical Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epitomee Medical Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
E
Epitomee Medical Ltd
TASE:EPIT
Free Cash Flow
-$12m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Free Cash Flow
-$48.1m
CAGR 3-Years
-11%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Free Cash Flow
-$1.1m
CAGR 3-Years
34%
CAGR 5-Years
28%
CAGR 10-Years
16%
Inmode Ltd
NASDAQ:INMD
Free Cash Flow
$161m
CAGR 3-Years
0%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Free Cash Flow
$33.1m
CAGR 3-Years
-7%
CAGR 5-Years
11%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Free Cash Flow
-$6.7m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Epitomee Medical Ltd
Glance View

Market Cap
279.6m ILS
Industry
Health Care

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

EPIT Intrinsic Value
275.46 ILS
Overvaluation 71%
Intrinsic Value
Price
E
What is Intrinsic Value?

See Also

What is Epitomee Medical Ltd's Free Cash Flow?
Free Cash Flow
-12m USD

Based on the financial report for Dec 31, 2023, Epitomee Medical Ltd's Free Cash Flow amounts to -12m USD.

What is Epitomee Medical Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
9%

Over the last year, the Free Cash Flow growth was 9%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.